TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36213929

Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention (5 days a week for 60 min each for 12 weeks)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention
Number of subjects: 60
Study: 36175048

Group type: EXPERIMENTAL
Intervention: 100 mg/d aspirin
Number of subjects: 12815

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12815
Study: 34547471

Group type: EXPERIMENTAL
Intervention: MB/IPL/PDT sessions (group A)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: IPL sessions (group B)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 80
Study: 35901105

Group type: EXPERIMENTAL
Intervention: Game-based high-intensity interval training (Game-HIIT) program
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Traditional game-based structured aerobic exercise (GameSAE) program
Number of subjects: 42

Group type: COMPARATOR
Intervention: Non-treatment control group (regular physical activity)
Number of subjects: 42
Study: 33468302

Group type: EXPERIMENTAL
Intervention: Ultrasonographic examination using a 5 MHz linear transducer
Number of subjects: 54

Group type: COMPARATOR
Intervention: Radiographs as the reference standard method
Number of subjects: 54
Study: 36006040

Group type: EXPERIMENTAL
Intervention: Intrarectal povidone‐iodine cleansing plus formalin disinfection of the needle tip
Number of subjects: 1256

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1256
Study: 34275593

Group type: EXPERIMENTAL
Intervention: Losartan (25 to 100 mg/day, flexibly titrated by week 6)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 149
Study: 33879183

Group type: EXPERIMENTAL
Intervention: Group Engage (values‐oriented behaviors)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Group Openness (acceptance and cognitive defusion)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Group Awareness (being present and aware)
Number of subjects: 90
Study: 33891569

Group type: EXPERIMENTAL
Intervention: Neem capsules (50 mg of neem-leaf extract, twice a day for 28 days)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Placebo capsules (twice a day for 28 days)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Neem capsules
Number of subjects: 190

Group type: COMPARATOR
Intervention: Neem capsules and Placebo
Number of subjects: 190
Study: 35551580

Group type: EXPERIMENTAL
Intervention: Vitamin D3 2000 IU/D for 12 weeks
Number of subjects: 90
Study: 34172012

Group type: EXPERIMENTAL
Intervention: Synbiotic formula
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Prebiotics
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Unsupplemented formula
Number of subjects: 153

Group type: COMPARATOR
Intervention: Vaginal birth (reference group)
Number of subjects: 153

Group type: COMPARATOR
Intervention: C-section birth
Number of subjects: 153
Study: 36379186

Group type: EXPERIMENTAL
Intervention: Sacituzumab govitecan (SG)
Number of subjects: 419

Group type: COMPARATOR
Intervention: Treatment of physician's choice (TPC)
Number of subjects: 419
Study: 34957020

Group type: EXPERIMENTAL
Intervention: Self-efficacy-focused structured education program (SSEP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine education
Number of subjects: 0
Study: 34023029

Group type: EXPERIMENTAL
Intervention: Intra-dialytic cycling (exercise group)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 101
Study: 35726893

Group type: EXPERIMENTAL
Intervention: PEEP of 8 mbar
Number of subjects: 382

Group type: COMPARATOR
Intervention: ZEEP
Number of subjects: 382
Study: 32000093

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT), 12 sessions
Number of subjects: 99

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 99
Study: 37670008

Group type: EXPERIMENTAL
Intervention: Stationary-bike exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Resting control condition
Number of subjects: 0
Study: 34446390

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 4012

Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 4012

Group type: EXPERIMENTAL
Intervention: Low eGFR
Number of subjects: 4012

Group type: COMPARATOR
Intervention: Ticagrelor vs Prasugrel
Number of subjects: 4012
Study: 34839074

Group type: EXPERIMENTAL
Intervention: CCRT
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: CRT
Number of subjects: 270

Group type: COMPARATOR
Intervention: Active control
Number of subjects: 270
Study: 33397420

Group type: EXPERIMENTAL
Intervention: Current alcohol use (any amount)
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Problem drinking behavior (identified by AUDIT)
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Hazardous drinking
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Active alcohol dependent behavior
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Predictors of maternal alcohol use
Number of subjects: 420
Study: 35000470

Group type: EXPERIMENTAL
Intervention: Stellarex low-dose paclitaxel drug-coated balloon (DCB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 0
Study: 32369162

Group type: EXPERIMENTAL
Intervention: Smoked cannabis administration (50.6 mg THC)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Vaporized cannabis administration (50.6 mg THC)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Oral cannabis administration (50.6 mg THC)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: All routes of administration
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: THC-glucuronide
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: THCCOOH, THC-glucuronide, and THCVCOOH
Number of subjects: 20
Study: 36096134

Group type: EXPERIMENTAL
Intervention: Continuous gastric feeding (CGF) over 2 hours
Number of subjects: 32

Group type: COMPARATOR
Intervention: Bolus feeding (BF) over 15-30 minutes
Number of subjects: 32
Study: 33736940

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (50‐54 Gy to the mediastinum using intensity‐modulated radiation therapy or proton beam therapy)
Number of subjects: 314

Group type: COMPARATOR
Intervention: Surveillance
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 314
Study: 32731936

Group type: EXPERIMENTAL
Intervention: Randomized clinical trials (RCTs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Common sense and clinical observation
Number of subjects: 0
Study: 35122323

Group type: EXPERIMENTAL
Intervention: Web-based educational intervention (self-education program with video and training questions)
Number of subjects: 284

Group type: COMPARATOR
Intervention: Non-education group (no educational intervention)
Number of subjects: 284
Study: 33047127

Group type: EXPERIMENTAL
Intervention: 6 mg nicotine/mL cherry
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 18 mg/mL cherry
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 6 mg/mL chocolate
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 18 mg/mL chocolate
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 39
Study: 35446902

Group type: EXPERIMENTAL
Intervention: Iron + Folic Acid + Counselling on Locally Available Dietary Intervention (IFA+LAD arm)
Number of subjects: 496

Group type: COMPARATOR
Intervention: Iron + Folic Acid (IFA arm)
Number of subjects: 496
Study: 33210434

Group type: EXPERIMENTAL
Intervention: 10 mg/mL triamcinolone acetonide (TA)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: 5 mg/mL triamcinolone acetonide (TA)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: 2.5 mg/mL triamcinolone acetonide (TA)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Normal saline (NS)
Number of subjects: 105
Study: 35791616

Group type: EXPERIMENTAL
Intervention: Green tea leaf extract (GTE) tablet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 0
Study: 35931636

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 + IIV4/PPV23 group
Number of subjects: 1152

Group type: COMPARATOR
Intervention: SARS-CoV-2 vaccine group
Number of subjects: 1152

Group type: COMPARATOR
Intervention: IIV4/PPV23 group
Number of subjects: 1152
Study: 33273290

Group type: EXPERIMENTAL
Intervention: Osteoporosis outreach program
Number of subjects: 10934

Group type: COMPARATOR
Intervention: No outreach
Number of subjects: 10934
Study: 35390511

Group type: EXPERIMENTAL
Intervention: Amantadine 200 mg per day for 14 days
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 32820003

Group type: EXPERIMENTAL
Intervention: Spiriva Respimat (2.5 μg twice a day) in combination with ICS/LABA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spiriva HandiHaler (18 μg once a day) in combination with ICS/LABA
Number of subjects: 0
Study: 33913348

Group type: EXPERIMENTAL
Intervention: Food and Nutrition Education Program with Sensory and Cognitive Exercises (PESC), consisting of four weekly workshops.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no workshops), evaluated twice with a one-month interval.
Number of subjects: 60
Study: 34994286

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine plus low dose contraceptive
Number of subjects: 100

Group type: COMPARATOR
Intervention: Low dose contraceptive alone
Number of subjects: 100
Study: 32135382

Group type: EXPERIMENTAL
Intervention: Prehabilitation Program (PP)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard Care (C)
Number of subjects: 70
Study: 36162791

Group type: EXPERIMENTAL
Intervention: Active network-tDCS (n=19)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sham network-tDCS (n=19)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Both groups (Active and Sham)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Active network-tDCS
Number of subjects: 38
Study: 33246064

Group type: EXPERIMENTAL
Intervention: Lorazepam (2.5 mg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 33201202

Group type: EXPERIMENTAL
Intervention: Care bundle including early intravenous nitrate boluses, management of precipitating factors, and moderate dose of intravenous diuretics (median 27.0 mg of intravenous nitrates in the first 4 hours).
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Care bundle (intervention group).
Number of subjects: 503

Group type: COMPARATOR
Intervention: Control group (usual care).
Number of subjects: 503
Study: 36111429

Group type: EXPERIMENTAL
Intervention: Erenumab (ERE) 140 mg
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Galcanezumab (GMB) 240 mg
Number of subjects: 65
Study: 34169412

Group type: EXPERIMENTAL
Intervention: Mindfulness intervention
Number of subjects: 3519

Group type: COMPARATOR
Intervention: Active control program (relaxation)
Number of subjects: 3519

Group type: COMPARATOR
Intervention: Inactive control group
Number of subjects: 3519
Study: 32791965

Group type: EXPERIMENTAL
Intervention: Pre-anesthesia best possible medication history (PA-BPMH) performed by a clinical pharmacist
Number of subjects: 455
Study: 35593290

Group type: EXPERIMENTAL
Intervention: Special platelet-rich plasma tubes centrifuged at 3500 rpm
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ordinary laboratory tubes centrifuged at 1000 rpm
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 30
Study: 33066980

Group type: EXPERIMENTAL
Intervention: Magnetotherapy (15 sessions of 20 minutes, 5 consecutive days per week)
Number of subjects: 19
Study: 32267856

Group type: EXPERIMENTAL
Intervention: Arithmetic mean
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Hölder mean M0.2
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Geometric mean
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Winsorized mean (0.1 cut-off)
Number of subjects: 49
Study: 35572833

Group type: EXPERIMENTAL
Intervention: Doctor-nurse-patient integrated nursing management
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine nursing
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Hessian matrix enhanced filter segmentation algorithm
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional CTA
Number of subjects: 120
Study: 32333158

Group type: EXPERIMENTAL
Intervention: TaTME (Transanal Total Mesorectal Excision)
Number of subjects: 173
Study: 36335415

Group type: EXPERIMENTAL
Intervention: Curcumin
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 32586771

Group type: EXPERIMENTAL
Intervention: Compatible crossmatches (n=39)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Incompatible crossmatches (n=11)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Comparison of compatible vs incompatible crossmatches
Number of subjects: 50
Study: 34482851

Group type: EXPERIMENTAL
Intervention: Nutrition education and cooking classes with produce allocations (PAE)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Nutrition education and cooking classes only (EO)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 36286834

Group type: EXPERIMENTAL
Intervention: Selective VDRA (zemplar 1 mcg/day)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Non-selective VDRA (alfacalcidol 0.25 mcg/day)
Number of subjects: 90
Study: 32712967

Group type: EXPERIMENTAL
Intervention: Suggestive seizure induction (group A)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Long-term video–electroencephalography (EEG) monitoring (group B)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Suggestive seizure induction
Number of subjects: 77

Group type: COMPARATOR
Intervention: Long-term monitoring
Number of subjects: 77

Group type: COMPARATOR
Intervention: Spontaneous PNES during long-term monitoring
Number of subjects: 77
Study: 35598547

Group type: EXPERIMENTAL
Intervention: Comprehensive Ayurveda and mindfulness-based Yoga (CAY)
Number of subjects: 356

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 356
Study: 32569068

Group type: EXPERIMENTAL
Intervention: Topical vancomycin powder (1000 mg)
Number of subjects: 58
Study: 34574383

Group type: EXPERIMENTAL
Intervention: IMPROVEjob intervention (two leadership workshops, toolbox with printed and online material, nine-month implementation phase)
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: IMPROVEjob intervention
Number of subjects: 366

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned in the abstract)
Number of subjects: 366
Study: 32179870

Group type: EXPERIMENTAL
Intervention: Higher dairy group (RDa; 4 servings/day)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Low dairy group (LDa; 0–2 servings/day)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both groups (RDa and LDa)
Number of subjects: 35
Study: 36410628

Group type: EXPERIMENTAL
Intervention: Topical lidocaine-prilocaine
Number of subjects: 90

Group type: COMPARATOR
Intervention: Ice packs
Number of subjects: 90
Study: 34420949

Group type: EXPERIMENTAL
Intervention: Daily supplementation with 2.3 g of omega-3 fatty acids (n-3 FAs)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 35061783

Group type: EXPERIMENTAL
Intervention: Indirect‐to‐Dads
Number of subjects: 857

Group type: EXPERIMENTAL
Intervention: Direct‐to‐Dads
Number of subjects: 857

Group type: EXPERIMENTAL
Intervention: Survey completion method
Number of subjects: 857

Group type: EXPERIMENTAL
Intervention: Healthcare access
Number of subjects: 857

Group type: EXPERIMENTAL
Intervention: Health behaviors
Number of subjects: 857
Study: 35428642

Group type: EXPERIMENTAL
Intervention: Work schedule without quick returns for 6 months
Number of subjects: 4000

Group type: COMPARATOR
Intervention: Work schedule that maintains quick returns for 6 months
Number of subjects: 4000
Study: 32577707

Group type: EXPERIMENTAL
Intervention: 5% sodium fluoride varnish with functionalized tri‐calcium phosphate (fTCP) applied at baseline and after 8 weeks
Number of subjects: 59

Group type: COMPARATOR
Intervention: Fluoride-free mock product (Control)
Number of subjects: 59
Study: 35899748

Group type: EXPERIMENTAL
Intervention: 2000 IU/day cholecalciferol (vitamin D) for 5 years
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: 1g/day omega-3 fatty acids for 5 years
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Combination of 2000 IU/day vitamin D and 1g/day omega-3 fatty acids for 5 years
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: 2000 IU/day vitamin D after 2 years
Number of subjects: 1000
Study: 34741088

Group type: EXPERIMENTAL
Intervention: THC-dominant concentrate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CBD-dominant concentrate
Number of subjects: 0
Study: 35897060

Group type: EXPERIMENTAL
Intervention: Trifluridine/tipiracil plus panitumumab (6 mg/kg body weight, intravenously on day 1 and 15, q28 days)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Trifluridine/tipiracil plus bevacizumab (5 mg/kg body weight, intravenously on day 1 and 15, q28 days)
Number of subjects: 153
Study: 34072155

Group type: EXPERIMENTAL
Intervention: Quantum Dots (QDs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bibliometric model for qualitative and quantitative evaluation
Number of subjects: 0
Study: 36096430

Group type: EXPERIMENTAL
Intervention: SpikoGen®
Number of subjects: 16876

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16876
Study: 33604666

Group type: EXPERIMENTAL
Intervention: Multivariate mixed linear model
Number of subjects: 172
Study: 32992898

Group type: EXPERIMENTAL
Intervention: Probiotics (Lactobacillus acidophilus, L. casei, L. helveticus, Bifidobacterium bifidum) for 60 days (n = 8)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (n = 7)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: High-protein/restricted dietary fiber (n = 12)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: High-protein/adequate dietary fiber (n = 10)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Adequate protein/restricted dietary fiber (n = 6)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Healthy sedentary subjects (n = 15)
Number of subjects: 28
Study: 34481963

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 100
Study: 32978696

Group type: COMPARATOR
Intervention: Melatonin (MLT) 40 mg/kg
Number of subjects: 3

Group type: COMPARATOR
Intervention: Folic acid (FA) 2 mg/kg
Number of subjects: 3

Group type: COMPARATOR
Intervention: Melatonin + Folic acid (MLT + FA)
Number of subjects: 3

Group type: COMPARATOR
Intervention: All experimental diets (including MLT, FA, MLT + FA)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control diet (basal diet)
Number of subjects: 3
Study: 35606865

Group type: EXPERIMENTAL
Intervention: Oral antibiotic bowel preparation (OABP) with neomycin 1 g and metronidazole 0.9 g the day before surgery
Number of subjects: 1500

Group type: COMPARATOR
Intervention: No special intestinal preparation (control group)
Number of subjects: 1500
Study: 33632187

Group type: EXPERIMENTAL
Intervention: Reciproc-Blue
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: WaveOne-Gold
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: XP-EndoShaper
Number of subjects: 30
Study: 35093842

Group type: EXPERIMENTAL
Intervention: Emotional Processing Intervention (EMOPRINT), a 12-session behavioral intervention teaching facial affect recognition skills and mimicry.
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo control group (no specific intervention details provided).
Number of subjects: 36
Study: 33068445

Group type: EXPERIMENTAL
Intervention: 3-point intramuscular injection technique (8-12 units of incobotulinumtoxinA)
Number of subjects: 48

Group type: COMPARATOR
Intervention: 6-point intradermal injection technique (8-12 units of incobotulinumtoxinA)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 3-point intramuscular injection technique
Number of subjects: 48

Group type: COMPARATOR
Intervention: 6-point intradermal injection technique
Number of subjects: 48
Study: 35881942

Group type: EXPERIMENTAL
Intervention: CBT-Meno
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 0
Study: 34111160

Group type: EXPERIMENTAL
Intervention: Above-elbow cast (AE)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Below-elbow cast (BE)
Number of subjects: 128
Study: 35092418

Group type: EXPERIMENTAL
Intervention: Letibotulinumtoxin A (20 U)
Number of subjects: 355

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 355
Study: 33236464

Group type: EXPERIMENTAL
Intervention: Metformin plus add-on linagliptin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Increased dose of metformin
Number of subjects: 50
Study: 35767683

Group type: EXPERIMENTAL
Intervention: Intradialytic range-of-motion exercises (30-minute weekly sessions)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 50
Study: 32870583

Group type: EXPERIMENTAL
Intervention: Intranasal chemical trigeminal stimulation with carbon dioxide
Number of subjects: 24
Study: 34687654

Group type: EXPERIMENTAL
Intervention: AGN‐151607 (botulinum toxin type A) 125 U (25 U / fat pad)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: AGN‐151607 (botulinum toxin type A) 250 U (50 U / fat pad)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 330
Study: 32213023

Group type: EXPERIMENTAL
Intervention: CAP with IQR/median <0.1
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: CAP with IQR/median <0.2
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: CAP with IQR/median <0.3
Number of subjects: 319

Group type: COMPARATOR
Intervention: CAP with IQR <40 dB/m
Number of subjects: 319
Study: 33992276

Group type: EXPERIMENTAL
Intervention: Neck stabilization exercise
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Pilates exercise
Number of subjects: 45

Group type: COMPARATOR
Intervention: Neck dynamic isometric exercise
Number of subjects: 45
Study: 33160359

Group type: EXPERIMENTAL
Intervention: Ramucirumab (10 mg/kg) plus docetaxel (75 mg/m2)
Number of subjects: 530

Group type: COMPARATOR
Intervention: Placebo plus docetaxel
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Ramucirumab (10 mg/kg) plus docetaxel
Number of subjects: 530
Study: 35396295

Group type: EXPERIMENTAL
Intervention: Statistically significant result (SSR) without spin
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Statistically significant result with spin
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Non-statistically significant result with spin
Number of subjects: 297

Group type: COMPARATOR
Intervention: Non-SSR without spin
Number of subjects: 297